2 days ago
July 29 (Reuters) - Medical device maker Boston Scientific on Wednesday lowered its annual profit forecast, citing pressure on its Watchman heart device business.
The company, in May, warned of pressure on its Watchman heart device, a small implant used to help prevent stroke-causing blood clots in patients with atrial fibrillation, due to softer-than-expected uptake.
Boston Scientific said growth was being weighed down by a decline in standalone Watchman procedures as physicians increasingly combine the implant with other cardiac treatments during a single visit.
As a result, the company said it expects flat Watchman revenue growth in the second and likely third quarter, despite continued uptake in combined procedures.
On Monday, Boston Scientific's board approved a new company-wide restructuring plan aimed at cutting costs and better positioning the company for future growth.
#uptake
The company, in May, warned of pressure on its Watchman heart device, a small implant used to help prevent stroke-causing blood clots in patients with atrial fibrillation, due to softer-than-expected uptake.
Boston Scientific said growth was being weighed down by a decline in standalone Watchman procedures as physicians increasingly combine the implant with other cardiac treatments during a single visit.
As a result, the company said it expects flat Watchman revenue growth in the second and likely third quarter, despite continued uptake in combined procedures.
On Monday, Boston Scientific's board approved a new company-wide restructuring plan aimed at cutting costs and better positioning the company for future growth.
#uptake
3 days ago
Citigroup (C) just gave income investors a fresh reason to look its way. On July 21, the bank announced a quarterly dividend of $0.67 per share to be paid on Aug. 28, 2026, to shareholders on record as of Aug. 3. That's an 11.7% increase from the previous $0.60 payout, and it comes right after Citigroup reported its strongest quarterly revenue in about a decade.
This didn't happen by chance. In its second-quarter 2026 earnings release, Citigroup posted $5.8 billion in net income and $24.77 billion in revenue, both ahead of expectations, while return on tangible common equity rose to 13%.
Broadcom Leads 3 AI Stocks Quietly Raising Their Dividends, One by 161%
Dear Lam Research Stock Fans, Mark Your Calendars for July 29
Apple Reports Q3 Earnings on July 30. Here's Why the AAPL Rally May Have More Room to Run.
#citigroup #quarterly #billion #stocks
This didn't happen by chance. In its second-quarter 2026 earnings release, Citigroup posted $5.8 billion in net income and $24.77 billion in revenue, both ahead of expectations, while return on tangible common equity rose to 13%.
Broadcom Leads 3 AI Stocks Quietly Raising Their Dividends, One by 161%
Dear Lam Research Stock Fans, Mark Your Calendars for July 29
Apple Reports Q3 Earnings on July 30. Here's Why the AAPL Rally May Have More Room to Run.
#citigroup #quarterly #billion #stocks
3 days ago
The markets always consist of differing views on companies — no single person has perfect information.
This rings home as KeyBanc Capital Markets sounded a bearish call on Apple's (AAPL) ahead of its earnings report this Thursday.
Quick insight: KeyBanc ****** yst Brandon Nispel reiterated an Underweight rating, or Sell, on Apple stock today. With a $250 price target, he expects Apple stock to plunge about 26% from current levels.
"With Apple providing a safe haven to the sell-off in semis, we think they are missing the bigger picture, which squarely fits our thesis: as Apple raises iPhone prices, unit growth will slow, and as unit growth slows, so will user growth, which we think ultimately will slow Services growth," Nispel said in a note.
"In addition, with Apple trading at ~34x P/E, and a growth profile that is shifting from volume-led growth to pricing-led growth, we think investors should apply a lower valuation multiple. To us, this makes Apple overvalued at current levels," he explained.
#Apple #sell #current #levels
This rings home as KeyBanc Capital Markets sounded a bearish call on Apple's (AAPL) ahead of its earnings report this Thursday.
Quick insight: KeyBanc ****** yst Brandon Nispel reiterated an Underweight rating, or Sell, on Apple stock today. With a $250 price target, he expects Apple stock to plunge about 26% from current levels.
"With Apple providing a safe haven to the sell-off in semis, we think they are missing the bigger picture, which squarely fits our thesis: as Apple raises iPhone prices, unit growth will slow, and as unit growth slows, so will user growth, which we think ultimately will slow Services growth," Nispel said in a note.
"In addition, with Apple trading at ~34x P/E, and a growth profile that is shifting from volume-led growth to pricing-led growth, we think investors should apply a lower valuation multiple. To us, this makes Apple overvalued at current levels," he explained.
#Apple #sell #current #levels
